0001165527-12-000803.txt : 20120904
0001165527-12-000803.hdr.sgml : 20120903
20120806101406
ACCESSION NUMBER: 0001165527-12-000803
CONFORMED SUBMISSION TYPE: CORRESP
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20120806
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PN Med Group Inc
CENTRAL INDEX KEY: 0001549084
STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
IRS NUMBER: 990367049
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: CORRESP
BUSINESS ADDRESS:
STREET 1: SAN ISIDRO 250, DEPTO 618
CITY: SANTIAGO
STATE: F3
ZIP: 8240400
BUSINESS PHONE: 569-659-22350
MAIL ADDRESS:
STREET 1: SAN ISIDRO 250, DEPTO 618
CITY: SANTIAGO
STATE: F3
ZIP: 8240400
CORRESP
1
filename1.txt
PN MED GROUP INC.
San Isidro 250, depot 618,
Santiago, Chile 8240400
Tel: 569-659-22350
Fax: 775-981-9001
Email: pnmedgroup@gmail.com
--------------------------------------------------------------------------------
August 6, 2012
Mr. H. Roger Schwall, Assistant Director
U.S. Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, D.C. 20549
Re: PN Med Group Inc.
Amendment No. 4 to Registration Statement on Form S-1
Filed July 11, 2012
File No. 333-181229
Dear Mr. Schwall:
This letter shall serve as the request of PN Med Group Inc., pursuant to Rule
461, to accelerate the effectiveness of the above-referenced Registration
Statement to Monday, August 6, 2012, 4:30PM EST, or the soonest practicable date
thereafter.
The Company further acknowledges the following:
* Should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filing;
* The action of the Commission or the staff, acting pursuant to
delegated authority, in declaring the filing effective, does not
relieve the Company from its full responsibility for the adequacy and
accuracy of the disclosure in the filing; and
* The Company may not assert staff comments and the declaration of
effectiveness as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the
United States.
Sincerely,
/s/ Pedro Perez Niklitschek
-------------------------------------
Pedro Niklitschek
President & Director